Use of botulinum toxin in hidradenitis suppurativa
Introduction: Hidradenitis suppurativa (HS) is an inflamatory, chronic, recurrent, and debilitating condition. There is a lack of consensus about its treatment. Objective: We conducted a review of the national and international literature, searching for articles that addressed the use of bo...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Brasileira de Dermatologia (SBD)
2021-12-01
|
| Series: | Surgical & Cosmetic Dermatology |
| Subjects: | |
| Online Access: | http://www.surgicalcosmetic.org.br/Content/imagebank/pdf/v13/13_n0_891_en.pdf |
| _version_ | 1828004654398570496 |
|---|---|
| author | Elcilane Gomes Silva Juliana Joyce Chaves de Lima Natalia Pantoja Costa |
| author_facet | Elcilane Gomes Silva Juliana Joyce Chaves de Lima Natalia Pantoja Costa |
| author_sort | Elcilane Gomes Silva |
| collection | DOAJ |
| description | Introduction: Hidradenitis suppurativa (HS) is an inflamatory, chronic, recurrent, and debilitating condition. There is a lack of consensus about its treatment.
Objective: We conducted a review of the national and international literature, searching for articles that addressed the use of botulinum toxin in HS, in addition to describing the doses and techniques used.
Methods: A bibliographic search was performed in LILACS, Medline, and SciELO.
Results: Botulinum toxin can be an effective therapy in patients with HS, especially in cases of concomitant hyperhidrosis and traditional therapies fail. It offers the possibility of conducting treatment with minimal adverse events, reproducible over time without loss of effectiveness, in addition to reducing pain.
Conclusions: Patients will likely need more than one treatment over time, as the lesions tend to recur after 6 to 10 months. The technique used has been the standard for hyperhidrosis. Further research is needed to understand its role in the management of HS, including the ideal dosage and frequency of administration. |
| first_indexed | 2024-04-10T07:18:20Z |
| format | Article |
| id | doaj.art-3f1a0827aabf4ebfb3ab5992e3bf3bb3 |
| institution | Directory Open Access Journal |
| issn | 1984-8773 |
| language | English |
| last_indexed | 2024-04-10T07:18:20Z |
| publishDate | 2021-12-01 |
| publisher | Sociedade Brasileira de Dermatologia (SBD) |
| record_format | Article |
| series | Surgical & Cosmetic Dermatology |
| spelling | doaj.art-3f1a0827aabf4ebfb3ab5992e3bf3bb32023-02-24T17:14:06ZengSociedade Brasileira de Dermatologia (SBD)Surgical & Cosmetic Dermatology1984-87732021-12-011310.5935/scd1984-8773.2021130013Use of botulinum toxin in hidradenitis suppurativaElcilane Gomes Silva0Juliana Joyce Chaves de Lima1Natalia Pantoja Costa2School of Medicine, Universidade do Estado do Pará, Belém (PA), BrazilSchool of Medicine, Centro Universitário Metropolitano da Amazônia, Belém (PA), BrazilSchool of Medicine, Universidade do Estado do Pará, Belém (PA), BrazilIntroduction: Hidradenitis suppurativa (HS) is an inflamatory, chronic, recurrent, and debilitating condition. There is a lack of consensus about its treatment. Objective: We conducted a review of the national and international literature, searching for articles that addressed the use of botulinum toxin in HS, in addition to describing the doses and techniques used. Methods: A bibliographic search was performed in LILACS, Medline, and SciELO. Results: Botulinum toxin can be an effective therapy in patients with HS, especially in cases of concomitant hyperhidrosis and traditional therapies fail. It offers the possibility of conducting treatment with minimal adverse events, reproducible over time without loss of effectiveness, in addition to reducing pain. Conclusions: Patients will likely need more than one treatment over time, as the lesions tend to recur after 6 to 10 months. The technique used has been the standard for hyperhidrosis. Further research is needed to understand its role in the management of HS, including the ideal dosage and frequency of administration.http://www.surgicalcosmetic.org.br/Content/imagebank/pdf/v13/13_n0_891_en.pdfhidradenitis suppurativahidradenitisbotulinum toxinsbotulinum toxins type a |
| spellingShingle | Elcilane Gomes Silva Juliana Joyce Chaves de Lima Natalia Pantoja Costa Use of botulinum toxin in hidradenitis suppurativa Surgical & Cosmetic Dermatology hidradenitis suppurativa hidradenitis botulinum toxins botulinum toxins type a |
| title | Use of botulinum toxin in hidradenitis suppurativa |
| title_full | Use of botulinum toxin in hidradenitis suppurativa |
| title_fullStr | Use of botulinum toxin in hidradenitis suppurativa |
| title_full_unstemmed | Use of botulinum toxin in hidradenitis suppurativa |
| title_short | Use of botulinum toxin in hidradenitis suppurativa |
| title_sort | use of botulinum toxin in hidradenitis suppurativa |
| topic | hidradenitis suppurativa hidradenitis botulinum toxins botulinum toxins type a |
| url | http://www.surgicalcosmetic.org.br/Content/imagebank/pdf/v13/13_n0_891_en.pdf |
| work_keys_str_mv | AT elcilanegomessilva useofbotulinumtoxininhidradenitissuppurativa AT julianajoycechavesdelima useofbotulinumtoxininhidradenitissuppurativa AT nataliapantojacosta useofbotulinumtoxininhidradenitissuppurativa |